ALMR logo

ALMR Alamar Biosciences, Inc.

NASDAQ Global Select · Biotechnology · Healthcare

$26.48
-2.20 (-7.67%)

Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is design…

Market Cap: $1.84Bwww.alamarbio.com

Price

No data yet.

Social Signal Score

57
5d
55
2 mentions
—
30d
59
7 mentions
—
60d
58
8 mentions
—
90d
58
8 mentions
—
news: 8

Analyst Ratings

3 analysts
Buyconsensus
Strong Buy 0Buy 3Hold 0Sell 0Strong Sell 0
Avg price target$32+20.8%
Low $32Median $32High $32
Current Consensus

Revenue

$33.55M+33.94%
$25.05M$27.88M$30.71M$33.55M
Dec 31Sep 30

Analyst Estimates

FY2026
$-1.19
$-1.21–$-1.17
3 analysts
FY2027
$-0.83
$-0.85–$-0.81
3 analysts
FY2028
$-0.42
$-0.67–$-0.27
4 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Yuling Luo
Sector
Healthcare
Industry
Biotechnology
Employees
308
Beta
-6.18
Country
US
www.alamarbio.com